Outcomes Following Percutaneous Cholecystostomy Tube Placement for Acalculous Versus Calculous Cholecystitis.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
accepted:
02
04
2022
pubmed:
18
4
2022
medline:
29
6
2022
entrez:
17
4
2022
Statut:
ppublish
Résumé
Acute acalculous cholecystitis (AAC) is often diagnosed in critically ill patients. Percutaneous cholecystostomy tube (PCT) placement facilitates less invasive gallbladder decompression in patients who are poor surgical candidates. Specific guidelines for optimal management of AAC patients following PCT placement remain to be defined. We hypothesize that AAC patients are at lower risk of recurrent cholecystitis than acute calculous cholecystitis (ACC) patients and do not require cholecystectomy after PCT placement. A retrospective review of patients who underwent PCT placement for AAC or ACC between 6/1/2007 and 5/31/2019 was performed. Primary outcome was recurrent cholecystitis and interval cholecystectomy for patients surviving 30 days after PCT placement. Secondary outcome was 30 day mortality. A cox regression model calculated the adjusted hazard ratio (AHR) for the outcomes. Eighty-four AAC and 85 ACC patients underwent PCT placement. Compared to ACC patients, more AAC patients were male (72.6 vs. 48.2%; p < 0.01), younger (median age 62 vs. 73 years; p < 0.01), and required intensive care (69.0 vs. 52.9%; p = 0.04), with lower median Charlson Comorbidity Index (4.0 vs. 6.0; p < 0.01). 30 day mortality was higher among AAC patients than ACC patients (45.2 vs. 21.2%; p < 0.01). 2/24 (8.3%) AAC patients and 5/31 (16.1%) ACC patients developed recurrent cholecystitis at a median 208.0 days (IQR:64.0-417.0) after PCT placement and 115.0 days (IQR:7.0-403.0) following PCT removal. Cox regression analysis demonstrated that AAC patients had lower likelihood of interval cholecystectomy compared to ACC patients (AHR 2.35; 95% CI:1.11,4.96). Recurrent cholecystitis is rare in patients surviving 30 days following PCT placement. When compared with ACC patients, fewer AAC patients require cholecystectomy.
Sections du résumé
BACKGROUND
Acute acalculous cholecystitis (AAC) is often diagnosed in critically ill patients. Percutaneous cholecystostomy tube (PCT) placement facilitates less invasive gallbladder decompression in patients who are poor surgical candidates. Specific guidelines for optimal management of AAC patients following PCT placement remain to be defined. We hypothesize that AAC patients are at lower risk of recurrent cholecystitis than acute calculous cholecystitis (ACC) patients and do not require cholecystectomy after PCT placement.
METHODS
A retrospective review of patients who underwent PCT placement for AAC or ACC between 6/1/2007 and 5/31/2019 was performed. Primary outcome was recurrent cholecystitis and interval cholecystectomy for patients surviving 30 days after PCT placement. Secondary outcome was 30 day mortality. A cox regression model calculated the adjusted hazard ratio (AHR) for the outcomes.
RESULTS
Eighty-four AAC and 85 ACC patients underwent PCT placement. Compared to ACC patients, more AAC patients were male (72.6 vs. 48.2%; p < 0.01), younger (median age 62 vs. 73 years; p < 0.01), and required intensive care (69.0 vs. 52.9%; p = 0.04), with lower median Charlson Comorbidity Index (4.0 vs. 6.0; p < 0.01). 30 day mortality was higher among AAC patients than ACC patients (45.2 vs. 21.2%; p < 0.01). 2/24 (8.3%) AAC patients and 5/31 (16.1%) ACC patients developed recurrent cholecystitis at a median 208.0 days (IQR:64.0-417.0) after PCT placement and 115.0 days (IQR:7.0-403.0) following PCT removal. Cox regression analysis demonstrated that AAC patients had lower likelihood of interval cholecystectomy compared to ACC patients (AHR 2.35; 95% CI:1.11,4.96).
CONCLUSION
Recurrent cholecystitis is rare in patients surviving 30 days following PCT placement. When compared with ACC patients, fewer AAC patients require cholecystectomy.
Identifiants
pubmed: 35430647
doi: 10.1007/s00268-022-06566-1
pii: 10.1007/s00268-022-06566-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1886-1895Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.
Références
Barie PS, Eachempati SR (2003) Acute acalculous cholecystitis. Curr Gastroenterol Rep 5:302–309. https://doi.org/10.1007/s11894-003-0067-x
doi: 10.1007/s11894-003-0067-x
pubmed: 12864960
Chung YH, Choi ER, Kim KM, Kim MJ, Lee JK, Lee KT et al (2012) Can percutaneous cholecystostomy be a definitive management for acute acalculous cholecystitis? J Clin Gastroenterol 46:216–219. https://doi.org/10.1097/MCG.0b013e3182274375
doi: 10.1097/MCG.0b013e3182274375
pubmed: 21814147
Kim SB, Gu MG, Kim KH, Kim TN (2020) Long-term outcomes of acute acalculous cholecystitis treated by non-surgical management. Med (United States) 99:1–4. https://doi.org/10.1097/MD.0000000000019057
doi: 10.1097/MD.0000000000019057
Huffman JL, Schenker S (2010) Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol 8:15–22. https://doi.org/10.1016/j.cgh.2009.08.034
doi: 10.1016/j.cgh.2009.08.034
pubmed: 19747982
Barie PS, Eachempati SR (2010) Acute acalculous cholecystitis. Gastroenterol Clin North Am 39:343–357. https://doi.org/10.1016/j.gtc.2010.02.012
doi: 10.1016/j.gtc.2010.02.012
pubmed: 20478490
Treinen C, Lomelin D, Krause C, Goede M, Oleynikov D (2015) Acute acalculous cholecystitis in the critically ill: risk factors and surgical strategies. Langenbeck’s Arch Surg 400:421–427. https://doi.org/10.1007/s00423-014-1267-6
doi: 10.1007/s00423-014-1267-6
Elsharif M, Forouzanfar A, Oaikhinan K, Khetan N (2018) Percutaneous cholecystostomy why, when, what next? A systematic review of past decade. Ann R Coll Surg Engl 100:618–31. https://doi.org/10.1308/rcsann.2018.0150
doi: 10.1308/rcsann.2018.0150
pmcid: 6204498
Ratanaprasatporn L, Uyeda JW, Wortman JR, Richardson I, Sodickson AD (2018) Multimodality imaging, including dual-energy CT, in the evaluation of gallbladder disease. Radiographics 38:75–89. https://doi.org/10.1148/rg.2018170076
doi: 10.1148/rg.2018170076
pubmed: 29320323
Bortoff GA, Chen MYM, Ott DJ, Wolfman NT, Routh WD (2000) Gallbladder stones: imaging and intervention. Radiographics 20:751–766. https://doi.org/10.1148/radiographics.20.3.g00ma16751
doi: 10.1148/radiographics.20.3.g00ma16751
pubmed: 10835126
Laor A, Tal S, Guller V, Zbar AP, Mavor E (2016) The charlson comorbidity index (CCI) as a mortality predictor after surgery in elderly patients. Am Surg 82:22–27. https://doi.org/10.1177/000313481608200113
doi: 10.1177/000313481608200113
pubmed: 26802847
Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY et al (2013) Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg 217:833-842.e3. https://doi.org/10.1016/j.jamcollsurg.2013.07.385
doi: 10.1016/j.jamcollsurg.2013.07.385
pubmed: 24055383
pmcid: 3805776
Kallini JR, Patel DC, Linaval N, Phillips EH, Van Allan RJ (2021) Comparing clinical outcomes of image-guided percutaneous transperitoneal and transhepatic cholecystostomy for acute cholecystitis. Acta Radiol 62:1142–1147. https://doi.org/10.1177/0284185120959829
doi: 10.1177/0284185120959829
pubmed: 32957795
Wang CH, Wu CY, Yang JCT, Lien WC, Wang HP, Liu KL et al (2016) Long-term outcomes of patients with acute cholecystitis after successful percutaneous cholecystostomy treatment and the risk factors for recurrence: a decade experience at a single center. PLoS One. https://doi.org/10.1371/journal.pone.0148017
doi: 10.1371/journal.pone.0148017
pubmed: 28036378
pmcid: 5201426
Anderson JE, Inui T, Talamini MA, Chang DC (2014) Cholecystostomy offers no survival benefit in patients with acute acalculous cholecystitis and severe sepsis and shock. J Surg Res 190:517–521. https://doi.org/10.1016/j.jss.2014.02.043
doi: 10.1016/j.jss.2014.02.043
pubmed: 24679697
Anderson JE, Chang DC, Talamini MA (2013) A nationwide examination of outcomes of percutaneous cholecystostomy compared with cholecystectomy for acute cholecystitis, 1998–2010. Surg Endosc 27:3406–3411. https://doi.org/10.1007/s00464-013-2924-5
doi: 10.1007/s00464-013-2924-5
pubmed: 23549767
Simorov A, Ranade A, Parcells J, Shaligram A, Shostrom V, Boilesen E et al (2013) Emergent cholecystostomy is superior to open cholecystectomy in extremely ill patients with acalculous cholecystitis: a large multicenter outcome study. Am J Surg 206:935–941. https://doi.org/10.1016/j.amjsurg.2013.08.019
doi: 10.1016/j.amjsurg.2013.08.019
pubmed: 24112675
Kirkegård J, Horn T, Christensen SD, Larsen LP, Knudsen AR, Mortensen FV (2015) Percutaneous cholecystostomy is an effective definitive treatment option for acute acalculous cholecystitis. Scand J Surg 104:238–243. https://doi.org/10.1177/1457496914564107
doi: 10.1177/1457496914564107
pubmed: 25567854
Boules M, Haskins IN, Farias-Kovac M, Guerron AD, Schechtman D, Samotowka M et al (2017) What is the fate of the cholecystostomy tube following percutaneous cholecystostomy? Surg Endosc 31:1707–1712. https://doi.org/10.1007/s00464-016-5161-x
doi: 10.1007/s00464-016-5161-x
pubmed: 27519595
Bhatt MN, Ghio M, Sadri L, Sarkar S, Kasotakis G, Narsule C et al (2018) Percutaneous cholecystostomy in acute cholecystitis—Predictors of recurrence and interval cholecystectomy. J Surg Res 232:539–546. https://doi.org/10.1016/j.jss.2018.06.051
doi: 10.1016/j.jss.2018.06.051
pubmed: 30463770
Sinvani L, Kuriakose R, Tariq S, Kozikowski A, Patel V, Smilios C et al (2019) Using charlson comorbidity index to predict short-term clinical outcomes in hospitalized older adults. J Healthc Qual 41:146–153. https://doi.org/10.1097/JHQ.0000000000000153
doi: 10.1097/JHQ.0000000000000153
pubmed: 31094947
Atherly A, Fink AS, Campbell DC, Mentzer RM, Henderson W, Khuri S et al (2004) Evaluating alternative risk-adjustment strategies for surgery. Am J Surg 188:566–570. https://doi.org/10.1016/j.amjsurg.2004.07.032
doi: 10.1016/j.amjsurg.2004.07.032
pubmed: 15546571
Noh SY, Gwon DI, Ko GY, Yoon HK, Sung KB (2018) Role of percutaneous cholecystostomy for acute acalculous cholecystitis: clinical outcomes of 271 patients. Eur Radiol 28:1449–55. https://doi.org/10.1007/s00330-017-5112-5
doi: 10.1007/s00330-017-5112-5
pubmed: 29116391
Loftus TJ, Brakenridge SC, Moore FA, Dessaigne CG, Sarosi GA, Zingarelli WJ et al (2017) Routine surveillance cholangiography after percutaneous cholecystostomy delays drain removal and cholecystectomy. J Trauma Acute Care Surg 82:351–355. https://doi.org/10.1097/TA.0000000000001315
doi: 10.1097/TA.0000000000001315
pubmed: 27893641
pmcid: 5250547
Hung Y, Chen H, Fu C, Tsai C, Chong S, Wang S et al (2020) Surgical outcomes of patients with maintained or removed percutaneous cholecystostomy before intended laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci 27:461–469. https://doi.org/10.1002/jhbp.740
doi: 10.1002/jhbp.740
pubmed: 32281739
Colonna AL, Griffiths TM, Robison DC, Enniss TM, Young JB, McCrum ML et al (2019) Cholecystostomy: are we using it correctly? Am J Surg 217:1010–1015. https://doi.org/10.1016/j.amjsurg.2019.04.002
doi: 10.1016/j.amjsurg.2019.04.002
pubmed: 31023549
Byrne MF, Suhocki P, Mitchell RM, Pappas TN, Stiffler HL, Jowell PS et al (2003) Percutaneous cholecystostomy in patients with acute cholecystitis: experience of 45 patients at a US referral center. J Am Coll Surg 197:206–211. https://doi.org/10.1016/S1072-7515(03)00143-1
doi: 10.1016/S1072-7515(03)00143-1
pubmed: 12892798